Skip to main content
Retour
UFPT logo

UFP Technologies, Inc.

Qualité des données : 100%
Survendu
UFPT
NASDAQ Healthcare Medical - Devices
188,76 €
▼ 2,29 € (-1,20%)
Cap. Boursière : 1,46B
Fourchette du Jour
188,20 € 196,96 €
Fourchette 52 Semaines
178,26 € 274,93 €
Volume
168 735
Moyenne 50J / 200J
236,81 € / 224,47 €
Clôture Précédente
191,05 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E 21,3 0,4
P/B 3,4 2,9
ROE % 17,8 3,8
Net Margin % 11,3 3,9
Rev Growth 5Y % 30,7 10,0
D/E 0,4 0,2

Points Clés

Revenue grew 30,74% annually over 5 years — strong growth
Earnings grew 15,82% over the past year
ROE of 17,82% — decent returns on equity
Debt/Equity of 0,36 — conservative balance sheet
Generating 78,98M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 11,24%

Croissance

Revenue Growth (5Y)
30,74%
Revenue (1Y)19,50%
Earnings (1Y)15,82%
FCF Growth (3Y)60,02%

Qualité

Return on Equity
17,82%
ROIC11,97%
Net Margin11,33%
Op. Margin15,32%

Sécurité

Debt / Equity
0,36
Current Ratio2,68
Interest Coverage9,42

Valorisation

P/E Ratio
21,31
P/B Ratio3,43
EV/EBITDA17,22
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 19,50% Revenue Growth (3Y) 22,75%
Earnings Growth (1Y) 15,82% Earnings Growth (3Y) 23,31%
Revenue Growth (5Y) 30,74% Earnings Growth (5Y) 44,00%
Profitability
Revenue (TTM) 602,80M Net Income (TTM) 68,31M
ROE 17,82% ROA 10,26%
Gross Margin 28,27% Operating Margin 15,32%
Net Margin 11,33% Free Cash Flow (TTM) 78,98M
ROIC 11,97% FCF Growth (3Y) 60,02%
Safety
Debt / Equity 0,36 Current Ratio 2,68
Interest Coverage 9,42 Dividend Yield 0,00%
Valuation
P/E Ratio 21,31 P/B Ratio 3,43
P/S Ratio 2,42 PEG Ratio 1,63
EV/EBITDA 17,22 Dividend Yield 0,00%
Market Cap 1,46B Enterprise Value 1,59B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 602,80M 504,42M 400,07M 353,79M 206,32M
Net Income 68,31M 58,98M 44,92M 41,79M 15,89M
EPS (Diluted) 8,77 7,58 5,83 5,45 2,09
Gross Profit 170,41M 146,69M 112,23M 90,26M 51,11M
Operating Income 92,34M 80,90M 57,66M 55,40M 21,22M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 665,74M 629,00M 404,14M 378,19M 334,13M
Total Liabilities 241,86M 286,24M 118,05M 140,65M 139,69M
Shareholders' Equity 423,88M 342,76M 286,09M 237,55M 194,45M
Total Debt 154,48M 206,03M 46,04M 68,37M 84,36M
Cash & Equivalents 20,30M 13,45M 5,26M 4,45M 11,12M
Current Assets 201,00M 194,95M 144,63M 116,35M 87,32M
Current Liabilities 74,86M 76,30M 58,21M 55,96M 38,78M

Scores de Stratégies

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#857 of 1024
28
Custom Balanced Risk
#56 of 148
50

Activité Récente

Entré Cash Flow Compounder
Mar 24, 2026
Entré Balanced Risk
Mar 24, 2026